Pharmafile Logo

How to elevate your communications testing with AI powered insights and analytics

Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers

Pharmaceutical companies strive to develop the most effective communication assets for their brands in order to maximise their impact. The challenge though is in identifying the messages and concepts that will have the greatest impact and influence with customers.

While there is now an appreciation of the subconscious behavioural biases that influence how we respond to marketing, many pharmaceutical companies are still developing and testing the majority of their communication campaigns based on more traditional insight gathering.

At Research Partnership, we have developed a behavioural science-led framework incorporating new AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers. watch this webcast to learn about the various components of this new approach and how each of them offered complementary benefits for a recent client who was looking to evaluate their creative concepts.

What you will learn

  • How innovative new technologies can complement traditional research techniques to provide a truer, multi-dimensional picture of how marketing communications perform with the target audience
  • How a new, behavioural science-led approach to communications research can take into account both instinctive and considered thinking as well as other behavioural biases to provide a more holistic evaluation of marketing materials
  • How to make use of AI, facial analysis and implicit response techniques to gain a 360-degree view of communications performance and how this can overcome the limitations of conducting market research remotely in a post-pandemic era

Watch the webcast

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Case Study: Oncology diagnostic biomarker landscaping study

The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...

Research Partnership publishes 2016 Living with RA reports

Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.

Article: The Art of Storytelling in Pharma Market Research

Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price...

The challenges of conducting effective pharmaceutical market research in emerging markets

Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets

Research Partnership appoints Director and Head of Business Analytics, North America

Tom has been appointed a Director in our Philadelphia office. He has over 25 years’ experience in healthcare research and has an extensive background in both quantitative and qualitative research,...

Article: The Art of Storytelling in Pharma Market Research

Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director

Event: EphMRA Annual Conference 2016

Frankfurt, Germany 21 - 23 June 2016

The challenges of conducting effective pharmaceutical market research in emerging markets

Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets

Blog: Viewing facility research, re-imagined

As technology has evolved, so too has the world of qualitative research